AVXL and AMPE - a stock study.
Consider the post referenced by this reply.
These charts is for those who think Anavex CEO Missling (a hire out of Wall Street with M&A experience) might not be operating in shareholders' best interest:
AMPE is likely to have a drug approved soon. They have been running at 10% institutional interest for years. They do not have an ATM in place and after the last dust up with the FDA (an "administrative" issue) they had to go back to the well for funding. Instys have now doubled their position and G-d knows how many they've added in the current quarter.
Compare AVXL and AMPE three year charts. It's pretty clear how money is repeatedly taken out of the system and retail investors are made into bagholders over and over.
If you were going to buy and hold since 2013, which one would you pick?
Consider the post referenced by this reply.
These charts is for those who think Anavex CEO Missling (a hire out of Wall Street with M&A experience) might not be operating in shareholders' best interest:
AMPE is likely to have a drug approved soon. They have been running at 10% institutional interest for years. They do not have an ATM in place and after the last dust up with the FDA (an "administrative" issue) they had to go back to the well for funding. Instys have now doubled their position and G-d knows how many they've added in the current quarter.
Compare AVXL and AMPE three year charts. It's pretty clear how money is repeatedly taken out of the system and retail investors are made into bagholders over and over.
If you were going to buy and hold since 2013, which one would you pick?
In Peace, In War
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
